rs1800562

mixedMag 8.5

This is a variant in the HFE gene that changes a cysteine to an tyrosine.

Key Literature Trait Associations

Hereditary Hemochromatosis

The C282Y mutation in HFE is the primary cause of hereditary hemochromatosis in Europeans. Homozygous carriers absorb excessive dietary iron, leading to iron overload that can damage the liver, heart, and pancreas if untreated. Penetrance is variable (~28% in males, lower in females).

Allen KJ et al. Iron-overload-related disease in HFE hereditary hemochromatosis. The New England Journal of Medicine (2008)
Allele A
OR
p
N 31,192
Preliminary work
European
Allele A
OR 64.00
p 1.0e-200
Large GWAS
Allele A
OR
p
N 35,478
Meta-analysis
multi-ancestry
Allele A
OR
p
N 6,020
Preliminary work
European
Allele A
OR 4.90
p 5.0e-3
N 2,890
Preliminary work
European

Porphyria cutanea tarda

HFE C282Y is one of the strongest known genetic risk factors for porphyria cutanea tarda (PCT), a disorder of heme synthesis triggered by hepatic iron overload. The large Ellervik et al. meta-analysis (202 studies, >290,000 individuals) found OR=48 (99% CI 24–95) for C282Y/C282Y homozygotes, OR=8.1 (99% CI 3.9–17) for compound heterozygotes (C282Y/H63D), and OR=3.6 (99% CI 1.8–7.3) for heterozygous carriers. Even a single A allele substantially elevates PCT risk, reflecting the iron-dependent pathophysiology of uroporphyrinogen decarboxylase inhibition. PCT can often be managed by phlebotomy to reduce iron burden, making genetic awareness clinically actionable.

Allele A
OR 48.00
p
N 292,778
Preliminary work
multi-ancestry

Hepatocellular carcinoma

The HFE C282Y A allele is associated with elevated hepatocellular carcinoma (HCC) susceptibility, particularly in homozygotes. A meta-analysis of 202 studies (66,263 cases, 226,515 controls) found C282Y/C282Y homozygosity associated with HCC risk (OR=11, 99% CI 3.7–34), and a European-specific meta-analysis (9 studies, 1,102 HCC cases, 3,766 controls) reported a Y allele OR of 1.50 (95% CI 1.05–2.14) overall, rising to OR=4.06 in alcoholic cirrhosis patients. A further meta-analysis (36 studies, ~87,000 individuals) confirmed increased cancer risk for C282Y homozygotes in a recessive model (OR=1.99, 95% CI 1.45–2.74), with HCC among the most affected cancer types. The likely mechanism is iron-mediated hepatic oxidative stress and fibrosis.

Allele A
OR 11.00
p
N 292,778
Preliminary work
multi-ancestry
Allele A
OR 1.99
p
N 87,028
Preliminary work
multi-ancestry
Allele A
OR 1.50
p 2.0e-2
N 4,868
Preliminary work
European

Serum transferrin measurement

The C282Y A allele is robustly associated with altered circulating iron biomarkers, including decreased serum transferrin (beta = −0.68 SD, p=1×10⁻¹⁰) and elevated transferrin saturation and serum ferritin in carriers. In Danish men, 89% of C282Y homozygotes showed elevated transferrin saturation and 94% had elevated ferritin ≥300 µg/L. A 2024 systematic review of 21 observational studies confirmed that HFE rs1800562 and rs1799945 exhibit protective effects against iron deficiency, meaning A allele carriers tend toward higher systemic iron stores. These biomarker shifts are the mechanistic basis underlying hemochromatosis, HCC, and PCT risks.

Allele A
OR
p
N 6,020
Preliminary work
European

Coronary artery disease

Mendelian randomization evidence suggests that the iron-raising A allele of rs1800562 is associated with modestly lower coronary artery disease (CAD) risk, consistent with a protective effect of higher iron status via downstream pathways. A two-sample MR study (60,801 CAD cases, 123,504 controls) using rs1800562 and two other HFE/TMPRSS6 variants as instruments found OR=0.94 per SD increase in iron biomarkers (95% CI 0.88–1.00, p=0.039). A larger phenome-wide MR (n=424,439, UK Biobank) further supported a protective effect on hypercholesterolemia with OR=0.72 (p=4×10⁻⁸). A meta-analysis of HFE variants in CHD found no direct significant association for rs1800562 itself, suggesting the CAD signal may be mediated through iron-related lipid and endothelial effects.

Allele A
OR 0.94
p 3.9e-2
N 184,305
Preliminary work
European
Allele A
OR 0.72
p 4.0e-8
N 424,439
Large GWAS
European
Allele A
OR
p
Candidate gene study
multi-ancestry

GWAS Catalog Trait Associations (49)

Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.

ClinVar annotation

Risk Factor
56 submitters85 publications

Hemochromatosis type 1; Hereditary cancer-predisposing syndrome; not provided; Hereditary hemochromatosis; Porphyrinuria;Cutaneous photosensitivity; 7 conditions; Bronze diabetes; Cardiomyopathy; HFE-related disorder; Inborn genetic diseases; 6 conditions; Juvenile hemochromatosis; Neuroendocrine neoplasm

View on ClinVar →

Research that mentions this SNP (8)

Patatin-like phospholipase domain-containing 3 I148M affects liver steatosis in patients with chronic hepatitis B
ReviewMauro Viganò et al.(2013)· Hepatology

This comprehensive review examines the genetic background of nonalcoholic fatty liver disease (NAFLD), focusing on variants identified by genome-wide association studies (GWAS) and candidate gene studies. The most significant GWAS-identified variants are PNPLA3 rs738409 (I148M), which strongly associates with increased liver steatosis, fibrosis severity, and HCC risk (12-fold increased risk for homozygous carriers), and TM6SF2 rs58542926 (E167K), which increases NASH progression but reduces cardiovascular risk. The review also discusses numerous candidate genes involved in lipid and glucose metabolism and liver injury mechanisms.

Traits studied:Cardiovascular diseaseChronic kidney diseaseCirrhosisHepatic injuryHepatic steatosisHepatocellular carcinomaInsulin resistanceLipid metabolismLiver fibrosisMetabolic syndromeNecroinflammationNonalcoholic fatty liver disease (NAFLD)Nonalcoholic steatohepatitis (NASH)ObesityType 2 diabetes
Association of glycosylated hemoglobin with the gene encoding CDKAL1 in the Korean Association Resource (KARE) study
Meta-analysisN=159,940Jihye Ryu et al.(2012)· Human Mutation

Transethnic genome-wide meta-analysis in 159,940 individuals identified 60 common genetic variants associated with HbA1c levels. Variants were classified as glycemic (19), erythrocytic (22), or unclassified (19) based on their biological mechanisms. Glycemic variants were associated with higher type 2 diabetes risk (OR=1.05 per allele, p=3×10⁻²⁹), while erythrocytic variants were not. The X-linked G6PD G202A variant showed a large effect in African Americans (0.81% HbA1c reduction per allele) but minimal effects in other ancestries, potentially causing 2% of African American T2D cases to remain undiagnosed when using HbA1c screening.

Traits studied:2-hour glucoseErythrocytic traitsFasting glucoseGlycemic traitsHemoglobin A1c (HbA1c)Type 2 diabetes
Lower serum hepcidin and greater parenchymal iron in nonalcoholic fatty liver disease patients with C282Y HFE mutations
AssociationN=786James E. Nelson et al.(2012)· Hepatology

This association study examined HFE gene mutations in 786 NAFLD patients from the NASH Clinical Research Network. NAFLD patients with C282Y mutations (rs1800562) had lower median serum hepcidin levels (57 vs 65 ng/ml, p=0.01) and higher mean hepatocellular iron grades (0.59 vs 0.28, p<0.001) compared to wild-type subjects. H63D mutations (rs1799945) were associated with higher steatosis grades and NAFLD activity scores (OR≥1.4, p≤0.041) but not with iron deposition, while C282Y mutations were associated with less ballooning or NASH (OR≤0.62, p≤0.024).

Traits studied:FibrosisHepatic iron depositionNAFLDNASHNonalcoholic fatty liver diseaseSteatosis
Genetic association analysis highlights new loci that modulate hematological trait variation in Caucasians and African Americans
AssociationN=30,551Ken Sin Lo et al.(2011)· Human Genetics

Genetic association study in 23,439 Caucasians and 7,112 African Americans identified novel loci modulating hematological traits. G6PD rs1050828 (Val68Met) shows strong association with red blood cell count, hemoglobin, hematocrit, and mean corpuscular volume in African Americans (P < 2.0 × 10^−13), while TPM4 rs8109288 associates with platelet count in both Caucasians and African Americans (P = 3.0 × 10^−7). HBA2-HBA1 rs1211375 associates with red blood cell traits specifically in African Americans (P < 7 × 10^−8). Study replicated 36 previously reported associations and highlights ethnic differences in genetic architecture of blood traits.

Traits studied:Basophil countEosinophil countHematocritHemoglobinLymphocyte countMean corpuscular hemoglobinMean corpuscular hemoglobin concentrationMean corpuscular volumeMean platelet volumeMonocyte countNeutrophil countPlatelet countRed blood cell countWhite blood cell count
Dissociation betweenAPOC3variants, hepatic triglyceride content and insulin resistance
ReviewJulia Kozlitina et al.(2011)· Hepatology

Comprehensive review of genetic background in nonalcoholic fatty liver disease (NAFLD). The PNPLA3 I148M variant (rs738409 C>G) is identified as a major genetic player strongly associated with increased liver fat content, NASH development, fibrosis severity, and HCC risk. The TM6SF2 E167K variant (rs58542926) emerges as another key contributor to NAFLD pathogenesis and disease progression. Multiple additional GWAS-identified variants and candidate genes are reviewed for their roles in NAFLD susceptibility and progression.

Traits studied:Alcoholic liver diseaseCardiovascular diseaseChronic kidney diseaseHCCHepatic steatosisHepatic triglyceridesHepatitis B steatosisHepatitis C progressionHepatocellular carcinomaInsulin resistanceLipid metabolismLiver fat contentLiver fibrosisNAFLDNASHNecroinflammationNonalcoholic fatty liver diseaseNonalcoholic steatohepatitisType 2 diabetes
Evaluation of the association studies of single nucleotide polymorphisms and hepatocellular carcinoma: a systematic review
Meta-analysisFei Jin et al.(2011)· Journal of Cancer Research and Clinical Oncology

A systematic review and meta-analysis of SNP associations with hepatocellular carcinoma (HCC) identified six SNPs in five genes with overall statistical significance. Two SNPs passed reliability criteria: rs1800562 (HFE, Cys282Tyr) with a recessive model OR of 5.20 (95% CI: 2.69-10.08) across 9 studies, and rs2279744 (MDM2) with an allele contrast OR of 1.57 (95% CI: 1.36-1.80) across 5 studies. Both were classified as having moderate epidemiological evidence by Venice guidelines.

Traits studied:Hepatocellular carcinoma
Suggestive synergy between genetic variants in TF and HFE as risk factors for Alzheimer's disease
AssociationN=2,570Kauwe JS et al.(2010)· American Journal of Medical Genetics Part B: Neuropsychiatric Genetics

This study replicates a previous finding of epistatic interaction between rs1049296 (P589S in TF) and rs1800562 (C282Y in HFE) as risk factors for Alzheimer's disease in a combined sample of 1,166 cases and 1,404 controls from three European and European American populations. The study found significant synergy between the two variants (synergy factor=2.71, p=0.0016 unadjusted; OR=2.4, p=0.002 adjusted for age and APOE ε4), with bi-carriers of minor alleles showing approximately 2.4-fold increased disease risk.

Traits studied:Alzheimer's diseaseLate-onset Alzheimer's disease
An extensive analysis of the hereditary hemochromatosis gene HFE and neighboring histone genes: associations with childhood leukemia
AssociationN=531Davis CF et al.(2010)· Annals of Hematology

Case-control study of 117 childhood acute lymphoblastic leukemia cases and 414 newborn controls from South Wales investigating the HFE gene and neighboring histone genes. Identified rs807212 as a tagging SNP for the common HFE haplotype with a strong male-specific protective association (adjusted OR=0.27 for heterozygotes, p=0.009) that accounts for the previously reported C282Y risk association. Analysis of 24 SNPs spanning 52 kb in the HFE region revealed complex haplotype structure with male-specific genetic effects.

Traits studied:Birth weightChildhood acute lymphoblastic leukemiaHemochromatosis

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…

rs1800562 (HFE) — genewizard.net